We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARD
1376
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$626K ﹤0.01%
+36,359
New +$603K
HOFT icon
1377
Hooker Furnishings Corp
HOFT
$149M
$624K ﹤0.01%
19,345
-28,169
-59% -$855K
EVBG
1378
DELISTED
Everbridge, Inc. Common Stock
EVBG
$621K ﹤0.01%
+4,165
New +$533K
NXST icon
1379
Nexstar Media Group
NXST
$5.92B
$620K ﹤0.01%
+5,681
New +$555K
AVD icon
1380
American Vanguard Corp
AVD
$75.8M
$615K ﹤0.01%
39,651
+23,899
+152% +$352K
DRI icon
1381
Darden Restaurants
DRI
$23.9B
$611K ﹤0.01%
5,126
-106,920
-95% -$11.5M
VIST icon
1382
Vista Energy
VIST
$7.12B
$609K ﹤0.01%
237,850
-8,162
-3% -$20.2K
DMAC icon
1383
DiaMedica Therapeutics
DMAC
$362M
$607K ﹤0.01%
+59,871
New +$328K
DCBO
1384
Docebo
DCBO
$529M
$606K ﹤0.01%
+9,321
New +$494K
CSOD
1385
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$606K ﹤0.01%
13,769
-141,003
-91% -$5.84M
DG icon
1386
Dollar General
DG
$27.8B
$605K ﹤0.01%
2,878
-32,520
-92% -$6.95M
ROST icon
1387
Ross Stores
ROST
$80.5B
$604K ﹤0.01%
+4,921
New +$516K
OLN icon
1388
Olin
OLN
$2.48B
$600K ﹤0.01%
24,410
-59,643
-71% -$1.21M
STN icon
1389
Stantec
STN
$8.2B
$599K ﹤0.01%
18,445
-105,644
-85% -$3.24M
GOLD
1390
Gold.com Inc
GOLD
$1.18B
$596K ﹤0.01%
46,498
+10,918
+31% +$171K
NXTC icon
1391
NextCure
NXTC
$21.7M
$596K ﹤0.01%
4,561
-4,131
-48% -$534K
TDW icon
1392
Tidewater
TDW
$3.75B
$596K ﹤0.01%
+68,917
New +$547K
TGI
1393
DELISTED
Triumph Group
TGI
$595K ﹤0.01%
+47,325
New +$491K
CQP icon
1394
Cheniere Energy
CQP
$30.5B
$594K ﹤0.01%
+16,846
New +$611K
EWY icon
1395
PUT
iShares MSCI South Korea ETF
EWY
$21.6B
$594K ﹤0.01%
+6,900
New +$511K
MRTN icon
1396
Marten Transport
MRTN
$1.26B
$594K ﹤0.01%
34,490
-9,150
-21% -$157K
TSEM icon
1397
Tower Semiconductor
TSEM
$23.3B
$594K ﹤0.01%
+22,864
New +$523K
DUK icon
1398
Duke Energy
DUK
$102B
$593K ﹤0.01%
+6,473
New +$599K
FPRX
1399
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$592K ﹤0.01%
+34,811
New +$436K
CMCL icon
1400
Caledonia Mining Corp
CMCL
$363M
$591K ﹤0.01%
37,198
-36,273
-49% -$600K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.